Dynamic Metabolic Changes during the First 3 Months after 90Y-Ibritumomab Tiuxetan Radioimmunotherapy
Figure 5
Axial images at level of inguinal region of patient 7. (a) Baseline, (b) 1-week scan, (c) 4-week scan, and (d) 12-week scan. FDG-avid lesion is seen in the right inguinal lesion (arrow). FDG uptake decrease for up to 4 weeks and the degree of the uptake is not remarkable at 4 weeks, but the declining metabolism turns to increase from 4 weeks to 12 weeks. Physiological activities are seen in the bladder and the rectum.
